Related Experiment Videos
Telomerase activation, cellular immortalization and cancer
1Department of Adult Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA. william_hahn@dfci.harvard.edu
Annals of Medicine
|May 1, 2001
Summary
Telomeres protect chromosome ends, preventing critical shortening that causes cell aging or death. Telomerase activation in cancer cells drives their growth, offering targets for new anti-cancer therapies.
Area of Science:
- Cell Biology
- Genetics
- Oncology
Background:
- Telomeres maintain chromosome stability, preventing cellular senescence or apoptosis due to progressive shortening.
- Telomerase activity is crucial for telomere maintenance but is repressed in most normal human somatic cells.
Purpose of the Study:
- To explore the role of telomerase regulation in human cancer development.
- To understand the mechanisms of telomerase activation in cancer.
- To identify potential therapeutic strategies targeting telomerase.
Main Methods:
- Analysis of telomere length dynamics during cell division.
- Investigation of telomerase catalytic subunit gene (hTERT) regulation in cancer cells.
- Assessment of ectopic hTERT expression effects on cellular immortalization.
Main Results:
- Telomere shortening triggers replicative senescence or apoptosis.
- Telomerase is activated in cancer cells, often via hTERT amplification or myc oncogene.
- Ectopic hTERT expression can immortalize various cell types.
Conclusions:
- Telomerase deregulation is a key factor in cancer development and progression.
- Targeting telomerase presents a promising antineoplastic strategy.
- Telomerase-mediated immortalization offers potential for therapeutic applications.